Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region
Clinical trial NCT03082976 · COMPLETED
Trial details
- NCT number
- NCT03082976
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-07-16
- Primary completion
- 2019-07-24
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.